Pediatric Hematology/Oncology Fellowship Program
At the Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta, we offer three-year pediatric Hematology/Oncology fellowships in collaboration with Emory University School of Medicine. Our program is among the largest pediatric hematology/oncology training programs in the country and the premiere program in the Southeast.
Additionally, our Pediatric Hematology/Oncology Fellowship Program offers:
- Blood and Marrow Transplant (BMT) and Cell Therapy Fellowship Program
- Pediatric Neuro-Oncology Fellowship Program
- T32 Hematology Training Program
- Combined Pediatric Hematology/Oncology Fellowship and PhD track
- Pediatric Cancer Survivorship Fellowship Program
Our goal is to train academically oriented hematologists and oncologists who will be involved in a lifetime of excellence in pediatric patient care, teaching and research. Fellows receive robust clinical training in pediatric oncology (leukemia/lymphoma, solid tumor, and neuro-oncology), hematology (general hematology, sickle cell disease, hemostasis/thrombosis, immunohematology), and bone marrow transplant. Second- and third-year fellows are offered a variety of opportunities in clinical, translational and basic research. In addition to research opportunities within the Aflac Cancer and Blood Disorders Center, fellows may collaborate with faculty at the Winship Cancer Institute of Emory University, Emory Rollins School of Public Health, Emory Laney Graduate School, Georgia Institute of Technology, Emory National Primate Research Center, and the Centers for Disease Control and Prevention (CDC). Fellows interested in clinical research have the opportunity to earn a Masters of Clinical Research (MSCR).
Learn more about the pediatric hematology-oncology fellowship including how to apply
T32 Hematology Training Program
T32 Hematology Training Program addresses the crucial need for programs to train physician scientists and clinical investigators in pediatric nonmalignant hematology. Research in hematology—particularly in pediatrics—has elucidated many of the genetic, cellular and molecular mechanisms underlying disease processes, as well as fundamental cellular functions such as cell differentiation and gene regulation. Embedded in the largest clinical pediatric hematology program in the country, our T32 training program provides huge patient volumes for clinical and translational research within Children’s Healthcare of Atlanta.
The T32 Hematology Training Program will offer rigorous training in basic and translational research to postdoctoral MD, MD/PhD and PhD fellows under the mentorship of 28 faculty mentors supported by more than $25 million in extramural funding (more than $17 million from federal sources). Integrated into the highly successful Pediatric Hematology/Oncology/Blood and Marrow Transplant Fellowship Program, the T32 Hematology Training Program will admit two trainees for two years of support, training five to seven MD fellows and three to five PhD postdoctoral fellows over five years.